Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy TherapeuticsMD stock | $1.23
Learn how to easily invest in TherapeuticsMD stock.
TherapeuticsMD, Inc is a drug manufacturers-specialty & generic business based in the US. TherapeuticsMD shares (TXMD) are listed on the NASDAQ and all prices are listed in US Dollars. TherapeuticsMD employs 400 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in TherapeuticsMD
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TXMD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
TherapeuticsMD stock price (NASDAQ: TXMD)Use our graph to track the performance of TXMD stocks over time.
TherapeuticsMD shares at a glance
|Latest market close||$1.23|
|52-week range||$0.93 - $2.65|
|50-day moving average||$1.18|
|200-day moving average||$1.35|
|Wall St. target price||$6.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.72|
Buy TherapeuticsMD shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy TherapeuticsMD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
TherapeuticsMD price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||3.36%|
|3 months (2021-04-29)||9.82%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
|Revenue TTM||$72.5 million|
|Gross profit TTM||$48.9 million|
|Return on assets TTM||-32.95%|
|Return on equity TTM||0%|
|Market capitalisation||$416.8 million|
TTM: trailing 12 months
Shorting TherapeuticsMD shares
There are currently 56.0 million TherapeuticsMD shares held short by investors – that's known as TherapeuticsMD's "short interest". This figure is 1.1% down from 56.6 million last month.
There are a few different ways that this level of interest in shorting TherapeuticsMD shares can be evaluated.
TherapeuticsMD's "short interest ratio" (SIR)
TherapeuticsMD's "short interest ratio" (SIR) is the quantity of TherapeuticsMD shares currently shorted divided by the average quantity of TherapeuticsMD shares traded daily (recently around 5.0 million). TherapeuticsMD's SIR currently stands at 11.11. In other words for every 100,000 TherapeuticsMD shares traded daily on the market, roughly 11110 shares are currently held short.
However TherapeuticsMD's short interest can also be evaluated against the total number of TherapeuticsMD shares, or, against the total number of tradable TherapeuticsMD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TherapeuticsMD's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 TherapeuticsMD shares in existence, roughly 140 shares are currently held short) or 0.1618% of the tradable shares (for every 100,000 tradable TherapeuticsMD shares, roughly 162 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against TherapeuticsMD.
Find out more about how you can short TherapeuticsMD stock.
TherapeuticsMD share dividends
We're not expecting TherapeuticsMD to pay a dividend over the next 12 months.
Have TherapeuticsMD's shares ever split?
TherapeuticsMD's shares were split on a 1:100 basis on 2 October 2011. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your TherapeuticsMD shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for TherapeuticsMD shares which in turn could have impacted TherapeuticsMD's share price.
TherapeuticsMD share price volatility
Over the last 12 months, TherapeuticsMD's shares have ranged in value from as little as $0.93 up to $2.65. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while TherapeuticsMD's is 1.9162. This would suggest that TherapeuticsMD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-007HR and TX-008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors.
Stocks similar to TherapeuticsMD
TherapeuticsMD in the news
Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know
TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
Frequently asked questionsWhat percentage of TherapeuticsMD is owned by insiders or institutions?
Currently 8.435% of TherapeuticsMD shares are held by insiders and 51.091% by institutions. How many people work for TherapeuticsMD?
Latest data suggests 400 work at TherapeuticsMD. When does the fiscal year end for TherapeuticsMD?
TherapeuticsMD's fiscal year ends in December. Where is TherapeuticsMD based?
TherapeuticsMD's address is: 951 Yamato Road, Boca Raton, FL, United States, 33431 What is TherapeuticsMD's ISIN number?
TherapeuticsMD's international securities identification number is: US88338N1072 What is TherapeuticsMD's CUSIP number?
TherapeuticsMD's Committee on Uniform Securities Identification Procedures number is: 03149A103
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert